182 related articles for article (PubMed ID: 15019891)
1. Heart rate dependent modification of the QTc cut-off values can improve accurate evaluation of QT prolongation.
Sadanaga T; Sadanaga F; Yao H; Fujishima M
Am J Cardiol; 2004 Mar; 93(6):772-5. PubMed ID: 15019891
[TBL] [Abstract][Full Text] [Related]
2. Sample size, power calculations, and their implications for the cost of thorough studies of drug induced QT interval prolongation.
Malik M; Hnatkova K; Batchvarov V; Gang Y; Smetana P; Camm AJ
Pacing Clin Electrophysiol; 2004 Dec; 27(12):1659-69. PubMed ID: 15613131
[TBL] [Abstract][Full Text] [Related]
3. Magnitude of error introduced by application of heart rate correction formulas to the canine QT interval.
King A; Bailie M; Olivier NB
Ann Noninvasive Electrocardiol; 2006 Oct; 11(4):289-98. PubMed ID: 17040276
[TBL] [Abstract][Full Text] [Related]
4. QT interval correction in patients with cirrhosis.
Zambruni A; Di Micoli A; Lubisco A; Domenicali M; Trevisani F; Bernardi M
J Cardiovasc Electrophysiol; 2007 Jan; 18(1):77-82. PubMed ID: 17229304
[TBL] [Abstract][Full Text] [Related]
5. Literature review and pilot studies of the effect of QT correction formulas on reported beta2-agonist-induced QTc prolongation.
Milic M; Bao X; Rizos D; Liu F; Ziegler MG
Clin Ther; 2006 Apr; 28(4):582-90. PubMed ID: 16750469
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of QTc prolongation in adult Nigerians with chronic heart failure.
Kolo PM; Opadijo OG; Omotoso AB; Balogun MO; Araoye MA; Katibi IA
West Afr J Med; 2008 Apr; 27(2):69-73. PubMed ID: 19025017
[TBL] [Abstract][Full Text] [Related]
7. Monitoring of QT interval in patients treated with psychotropic drugs.
Novotny T; Florianova A; Ceskova E; Weislamplova M; Palensky V; Tomanova J; Sisakova M; Toman O; Spinar J
Int J Cardiol; 2007 May; 117(3):329-32. PubMed ID: 16863665
[TBL] [Abstract][Full Text] [Related]
8. Importance of hepatitis C coinfection in the development of QT prolongation in HIV-infected patients.
Nordin C; Kohli A; Beca S; Zaharia V; Grant T; Leider J; Marantz P
J Electrocardiol; 2006 Apr; 39(2):199-205. PubMed ID: 16580420
[TBL] [Abstract][Full Text] [Related]
9. An evaluation of ECG leads used to assess QT prolongation.
Sadanaga T; Sadanaga F; Yao H; Fujishima M
Cardiology; 2006; 105(3):149-54. PubMed ID: 16449814
[TBL] [Abstract][Full Text] [Related]
10. Reproducibility of corrected QT interval in pediatric genotyped long QT syndrome.
Ogawa Y; Tanaka T; Kido S
Pediatr Int; 2016 Nov; 58(11):1246-1248. PubMed ID: 27882731
[TBL] [Abstract][Full Text] [Related]
11. [Predictive value of ECG changes for acute cardiac rejections in heart transplant recipients].
Tenderich G; Jahanyar J; Zittermann A; Schleithoff SS; Wlost S; Körfer R
Med Klin (Munich); 2006 Feb; 101(2):99-106. PubMed ID: 16501906
[TBL] [Abstract][Full Text] [Related]
12. Frequency and prognostic significance of QT prolongation in chronic renal failure patients.
Voiculescu M; Ionescu C; Ismail G
Rom J Intern Med; 2006; 44(4):407-17. PubMed ID: 18386617
[TBL] [Abstract][Full Text] [Related]
13. Differences between study-specific and subject-specific heart rate corrections of the QT interval in investigations of drug induced QTc prolongation.
Malik M; Hnatkova K; Batchvarov V
Pacing Clin Electrophysiol; 2004 Jun; 27(6 Pt 1):791-800. PubMed ID: 15189536
[TBL] [Abstract][Full Text] [Related]
14. Effects of treatment with somatostatin analogues on QT interval duration in acromegalic patients.
Fatti LM; Scacchi M; Lavezzi E; Pecori Giraldi F; De Martin M; Toja P; Michailidis G; Stramba-Badiale M; Cavagnini F
Clin Endocrinol (Oxf); 2006 Nov; 65(5):626-30. PubMed ID: 17054464
[TBL] [Abstract][Full Text] [Related]
15. Measuring the effects of supratherapeutic doses of levofloxacin on healthy volunteers using four methods of QT correction and periodic and continuous ECG recordings.
Noel GJ; Goodman DB; Chien S; Solanki B; Padmanabhan M; Natarajan J
J Clin Pharmacol; 2004 May; 44(5):464-73. PubMed ID: 15102866
[TBL] [Abstract][Full Text] [Related]
16. Relation of increased short-term variability of QT interval to congenital long-QT syndrome.
Hinterseer M; Beckmann BM; Thomsen MB; Pfeufer A; Dalla Pozza R; Loeff M; Netz H; Steinbeck G; Vos MA; Kääb S
Am J Cardiol; 2009 May; 103(9):1244-8. PubMed ID: 19406266
[TBL] [Abstract][Full Text] [Related]
17. Influence of promethazine on cardiac repolarisation: a double-blind, midazolam-controlled study.
Owczuk R; Twardowski P; Dylczyk-Sommer A; Wujtewicz MA; Sawicka W; Drogoszewska B; Wujtewicz M
Anaesthesia; 2009 Jun; 64(6):609-14. PubMed ID: 19453313
[TBL] [Abstract][Full Text] [Related]
18. The effect of intravenous lidocaine on QT changes during tracheal intubation.
Owczuk R; Wujtewicz MA; Sawicka W; Piankowski A; Polak-Krzeminska A; Morzuch E; Wujtewicz M
Anaesthesia; 2008 Sep; 63(9):924-31. PubMed ID: 18547294
[TBL] [Abstract][Full Text] [Related]
19. Cut-offs for screening prolonged QT intervals from Fridericia's formula in children and adolescents.
Hazeki D; Yoshinaga M; Takahashi H; Tanaka Y; Haraguchi Y; Abe M; Koga M; Fukushige T; Nagashima M
Circ J; 2010 Aug; 74(8):1663-9. PubMed ID: 20534944
[TBL] [Abstract][Full Text] [Related]
20. Application of probabilistic analysis for precisely correcting the QT interval for heart rate in telemetered common marmosets.
Honda M; Komatsu R; Holzgrefe HH; Yamada Y; Isobe T; Kimura K; Itoh T; Tamaoki N; Tabo M
J Pharmacol Toxicol Methods; 2010; 61(3):264-70. PubMed ID: 20097297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
